{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:17:51Z","timestamp":1794435471798,"version":"4.9.1"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82305298"],"award-info":[{"award-number":["82305298"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China Postdoctoral Science Foundation funded project","award":["2022M720521"],"award-info":[{"award-number":["2022M720521"]}]},{"name":"The Central High-level Hospital of Traditional Chinese Medicine: Beijing University of Traditional Chinese Medicine Dongzhimen Hospital Talent Training Program-Youth Reserve Talent Project","award":["DZMG-QNHB0010"],"award-info":[{"award-number":["DZMG-QNHB0010"]}]},{"name":"Beijing University of Chinese Medicine Dongzhimen Hospital Clinical research and achievement transformation ability improvement project-Youth special project","award":["DZMG-QNZX-24003"],"award-info":[{"award-number":["DZMG-QNZX-24003"]}]},{"name":"Chinese Association of Traditional Chinese Medicine - Young Talent lifting project","award":["2024-QNRC2-B36"],"award-info":[{"award-number":["2024-QNRC2-B36"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Polycystic ovary syndrome (PCOS) is an endocrine metabolic syndrome characterized by ovulation disorders, hyperandrogenemia, and polycystic ovaries, which seriously affect the psychological and physical health of childbearing women. N6-methyladenosine (m6A), as the most common mRNA epigenetic modification in eukaryotes, is vital for developing the female reproductive system and reproductive diseases. In recent years, an increasing number of studies have revealed the mechanisms by which m6A modifications and their related proteins are promoting the development of PCOS, including writers, erasers and readers. In this work, we reviewed the research progress of m6A in the pathophysiological development of PCOS from the starting point of PCOS clinical features, included the recent studies or those with significant findings related to m6A and PCOS, summarized the current commonly used therapeutic methods in PCOS and the possible targeted therapies against the m6A mechanism, and looked forward to future research directions of m6A in PCOS. With the gradual revelation of the m6A mechanism, m6A and its related proteins are expected to become a great field for PCOS treatment.<\/jats:p>","DOI":"10.1186\/s13048-025-01690-7","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:03:09Z","timestamp":1747994589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome"],"prefix":"10.1186","volume":"18","author":[{"given":"Leyi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangzhen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangliang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhinan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"issue":"12","key":"1690_CR1","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841\u201355.","journal-title":"Hum Reprod"},{"key":"1690_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27\u201336.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"1690_CR3","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"S Siddiqui","year":"2022","unstructured":"Siddiqui S, et al. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39(11):2439\u201373.","journal-title":"J Assist Reprod Genet"},{"issue":"7","key":"1690_CR4","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, et al. Chronic Low Grade Inflammation in Pathogenesis of PCOS. Int J Mol Sci. 2021;22(7):3789.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1690_CR5","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447\u201369.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1690_CR6","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1016\/j.fertnstert.2009.09.018","volume":"93","author":"AA Deeks","year":"2010","unstructured":"Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril. 2010;93(7):2421\u20133.","journal-title":"Fertil Steril"},{"issue":"11","key":"1690_CR7","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1007\/s43032-021-00765-2","volume":"29","author":"JV Kolhe","year":"2022","unstructured":"Kolhe JV, et al. PCOS and Depression: Common Links and Potential Targets. Reprod Sci. 2022;29(11):3106\u201323.","journal-title":"Reprod Sci"},{"issue":"12","key":"1690_CR8","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","volume":"25","author":"S Risal","year":"2019","unstructured":"Risal S, et al. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat Med. 2019;25(12):1894\u2013904.","journal-title":"Nat Med"},{"issue":"7","key":"1690_CR9","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/humrep\/deaa099","volume":"35","author":"G Mills","year":"2020","unstructured":"Mills G, et al. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Hum Reprod. 2020;35(7):1666\u201374.","journal-title":"Hum Reprod"},{"issue":"1","key":"1690_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"1690_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrg.2016.93","volume":"17","author":"PA Jones","year":"2016","unstructured":"Jones PA, Issa JP, Baylin S. Targeting the cancer epigenome for therapy. Nat Rev Genet. 2016;17(10):630\u201341.","journal-title":"Nat Rev Genet"},{"key":"1690_CR12","doi-asserted-by":"publisher","first-page":"105937","DOI":"10.1016\/j.phrs.2021.105937","volume":"174","author":"B Yang","year":"2021","unstructured":"Yang B, et al. RNA methylation and cancer treatment. Pharmacol Res. 2021;174:105937.","journal-title":"Pharmacol Res"},{"key":"1690_CR13","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1017\/erm.2021.4","volume":"23","author":"X Dai","year":"2021","unstructured":"Dai X, et al. Methylation multiplicity and its clinical values in cancer. Expert Rev Mol Med. 2021;23:e2.","journal-title":"Expert Rev Mol Med"},{"issue":"Database issue","key":"1690_CR14","doi-asserted-by":"publisher","first-page":"D145","DOI":"10.1093\/nar\/gkj084","volume":"34","author":"S Dunin-Horkawicz","year":"2006","unstructured":"Dunin-Horkawicz S, et al. MODOMICS: a database of RNA modification pathways. Nucleic Acids Res. 2006;34(Database issue):D145\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"1690_CR15","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1261\/rna.063503.117","volume":"23","author":"N Jonkhout","year":"2017","unstructured":"Jonkhout N, et al. The RNA modification landscape in human disease. RNA. 2017;23(12):1754\u201369.","journal-title":"RNA"},{"issue":"7","key":"1690_CR16","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, et al. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169(7):1187\u2013200.","journal-title":"Cell"},{"issue":"9","key":"1690_CR17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668\u201380.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"1690_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41574-021-00517-x","volume":"17","author":"E Stener-Victorin","year":"2021","unstructured":"Stener-Victorin E, Deng Q. Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment. Nat Rev Endocrinol. 2021;17(9):521\u201333.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"1690_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000519302","volume":"77","author":"X Che","year":"2021","unstructured":"Che X, et al. Dietary interventions: a promising treatment for polycystic ovary syndrome. Ann Nutr Metab. 2021;77(6):313\u201323.","journal-title":"Ann Nutr Metab"},{"issue":"10","key":"1690_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/09513590.2021.1958310","volume":"37","author":"J Coll\u00e9e","year":"2021","unstructured":"Coll\u00e9e J, et al. Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecol Endocrinol. 2021;37(10):869\u201374.","journal-title":"Gynecol Endocrinol"},{"key":"1690_CR21","first-page":"Cd007689","volume":"8","author":"DC Lim","year":"2011","unstructured":"Lim DC, et al. Acupuncture for polycystic ovarian syndrome. Cochrane Database Syst Rev. 2011;8:Cd007689.","journal-title":"Cochrane Database Syst Rev"},{"key":"1690_CR22","doi-asserted-by":"publisher","first-page":"681238","DOI":"10.3389\/fcell.2021.681238","volume":"9","author":"X Liu","year":"2021","unstructured":"Liu X, et al. The latest research progress of m(6)A modification and its writers, erasers, readers in infertility: a review. Front Cell Dev Biol. 2021;9:681238.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1690_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21(1):14.","journal-title":"Mol Cancer"},{"issue":"9","key":"1690_CR24","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.7150\/ijbs.69771","volume":"18","author":"J Chen","year":"2022","unstructured":"Chen J, et al. Role of m6A modification in female infertility and reproductive system diseases. Int J Biol Sci. 2022;18(9):3592\u2013604.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1690_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12964-023-01078-4","volume":"21","author":"E Huang","year":"2023","unstructured":"Huang E, Chen L. RNA N(6)-methyladenosine modification in female reproductive biology and pathophysiology. Cell Commun Signal. 2023;21(1):53.","journal-title":"Cell Commun Signal"},{"key":"1690_CR26","doi-asserted-by":"publisher","first-page":"884295","DOI":"10.3389\/fcell.2022.884295","volume":"10","author":"X Sun","year":"2022","unstructured":"Sun X, et al. The role of m(6)A on female reproduction and fertility: from Gonad development to ovarian aging. Front Cell Dev Biol. 2022;10:884295.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"1690_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41419-021-04272-9","volume":"12","author":"H Mu","year":"2021","unstructured":"Mu H, et al. METTL3-mediated mRNA N(6)-methyladenosine is required for oocyte and follicle development in mice. Cell Death Dis. 2021;12(11):989.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1690_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/15384101.2019.1711324","volume":"19","author":"X Sui","year":"2020","unstructured":"Sui X, et al. METTL3-mediated m(6)A is required for murine oocyte maturation and maternal-to-zygotic transition. Cell Cycle. 2020;19(4):391\u2013404.","journal-title":"Cell Cycle"},{"issue":"6225","key":"1690_CR29","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.1261417","volume":"347","author":"S Geula","year":"2015","unstructured":"Geula S, et al. Stem cells. m6A mRNA methylation facilitates resolution of na\u00efve pluripotency toward differentiation. Science. 2015;347(6225):1002\u20136.","journal-title":"Science"},{"issue":"1","key":"1690_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13148-023-01487-9","volume":"15","author":"K Liu","year":"2023","unstructured":"Liu K, et al. Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome. Clin Epigenetics. 2023;15(1):86.","journal-title":"Clin Epigenetics"},{"issue":"21","key":"1690_CR31","doi-asserted-by":"publisher","first-page":"9024","DOI":"10.1158\/0008-5472.CAN-08-2494","volume":"68","author":"MH Aziz","year":"2008","unstructured":"Aziz MH, Dreckschmidt NE, Verma AK. Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res. 2008;68(21):9024\u201332.","journal-title":"Cancer Res"},{"issue":"1","key":"1690_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13048-022-01058-1","volume":"15","author":"Z Cai","year":"2022","unstructured":"Cai Z, et al. Plumbagin rescues the granulosa cell\u2019s pyroptosis by reducing WTAP-mediated N6-methylation in polycystic ovary syndrome. J Ovarian Res. 2022;15(1):126.","journal-title":"J Ovarian Res"},{"issue":"8","key":"1690_CR33","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1038\/s41418-020-0516-1","volume":"27","author":"Y Hu","year":"2020","unstructured":"Hu Y, et al. Oocyte competence is maintained by m(6)A methyltransferase KIAA1429-mediated RNA metabolism during mouse follicular development. Cell Death Differ. 2020;27(8):2468\u201383.","journal-title":"Cell Death Differ"},{"issue":"5855","key":"1690_CR34","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1126\/science.1151710","volume":"318","author":"T Gerken","year":"2007","unstructured":"Gerken T, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007;318(5855):1469\u201372.","journal-title":"Science"},{"issue":"10","key":"1690_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.5603\/GP.a2020.0176","volume":"92","author":"F Beyazit","year":"2021","unstructured":"Beyazit F, et al. Serum spexin, adiponectin and leptin levels in polycystic ovarian syndrome in association with FTO gene polymorphism. Ginekol Pol. 2021;92(10):682\u20138.","journal-title":"Ginekol Pol"},{"issue":"5","key":"1690_CR36","doi-asserted-by":"publisher","first-page":"e1007412","DOI":"10.1371\/journal.pgen.1007412","volume":"14","author":"SD Kasowitz","year":"2018","unstructured":"Kasowitz SD, et al. Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. PLoS Genet. 2018;14(5):e1007412.","journal-title":"PLoS Genet"},{"issue":"9","key":"1690_CR37","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1093\/oxfordjournals.humrep.a136278","volume":"10","author":"DA Magoffin","year":"1995","unstructured":"Magoffin DA, San Roman GA, Muderspach LI. Insulin-like growth factor binding proteins in a natural pre-ovulatory follicle from a woman with polycystic ovary syndrome. Hum Reprod. 1995;10(9):2248\u201352.","journal-title":"Hum Reprod"},{"key":"1690_CR38","doi-asserted-by":"publisher","first-page":"115467","DOI":"10.1016\/j.envpol.2020.115467","volume":"267","author":"H Zhang","year":"2020","unstructured":"Zhang H, et al. Constant light exposure causes oocyte meiotic defects and quality deterioration in mice. Environ Pollut. 2020;267:115467.","journal-title":"Environ Pollut"},{"issue":"11","key":"1690_CR39","doi-asserted-by":"publisher","first-page":"e3847","DOI":"10.1210\/clinem\/dgaa515","volume":"105","author":"BY Jarrett","year":"2020","unstructured":"Jarrett BY, et al. Ultrasound characterization of disordered antral follicle development in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2020;105(11):e3847\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"1690_CR40","doi-asserted-by":"publisher","first-page":"1175384","DOI":"10.3389\/fimmu.2023.1175384","volume":"14","author":"W Chen","year":"2023","unstructured":"Chen W, et al. Shared diagnostic genes and potential mechanism between PCOS and recurrent implantation failure revealed by integrated transcriptomic analysis and machine learning. Front Immunol. 2023;14:1175384.","journal-title":"Front Immunol"},{"issue":"3","key":"1690_CR41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.fertnstert.2004.11.020","volume":"83","author":"WA Palomino","year":"2005","unstructured":"Palomino WA, et al. Differential expression of endometrial integrins and progesterone receptor during the window of implantation in normo-ovulatory women treated with clomiphene citrate. Fertil Steril. 2005;83(3):587\u201393.","journal-title":"Fertil Steril"},{"issue":"4","key":"1690_CR42","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.fertnstert.2005.09.053","volume":"85","author":"S Quezada","year":"2006","unstructured":"Quezada S, et al. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome. Fertil Steril. 2006;85(4):1017\u201326.","journal-title":"Fertil Steril"},{"issue":"1","key":"1690_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2014.10.022","volume":"129","author":"MC Baracat","year":"2015","unstructured":"Baracat MC, et al. Systematic review of cell adhesion molecules and estrogen receptor expression in the endometrium of patients with polycystic ovary syndrome. Int J Gynaecol Obstet. 2015;129(1):1\u20134.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"1690_CR44","doi-asserted-by":"publisher","first-page":"23100","DOI":"10.1038\/s41598-024-74295-7","volume":"14","author":"SY Wei","year":"2024","unstructured":"Wei SY, et al. High androgen level during controlled ovarian stimulation cycle impairs endometrial receptivity in PCOS patients. Sci Rep. 2024;14(1):23100.","journal-title":"Sci Rep"},{"key":"1690_CR45","doi-asserted-by":"publisher","first-page":"617172","DOI":"10.3389\/fcell.2021.617172","volume":"9","author":"W Qiu","year":"2021","unstructured":"Qiu W, et al. RNA demethylase FTO mediated RNA m(6)A modification is involved in maintaining maternal-fetal interface in spontaneous abortion. Front Cell Dev Biol. 2021;9:617172.","journal-title":"Front Cell Dev Biol"},{"issue":"13","key":"1690_CR46","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.7150\/thno.31868","volume":"9","author":"XC Li","year":"2019","unstructured":"Li XC, et al. The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA. Theranostics. 2019;9(13):3853\u201365.","journal-title":"Theranostics"},{"issue":"2","key":"1690_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/19396368.2020.1860155","volume":"67","author":"H Fu","year":"2021","unstructured":"Fu H, et al. Correlation between anti-Mullerian hormone levels and antral follicle counts in polycystic ovary and metabolic syndromes. Syst Biol Reprod Med. 2021;67(2):112\u201320.","journal-title":"Syst Biol Reprod Med"},{"issue":"8","key":"1690_CR48","doi-asserted-by":"publisher","first-page":"e0235404","DOI":"10.1371\/journal.pone.0235404","volume":"15","author":"H Kuang","year":"2020","unstructured":"Kuang H, et al. The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome. PLoS ONE. 2020;15(8):e0235404.","journal-title":"PLoS ONE"},{"issue":"5","key":"1690_CR49","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.1002\/jcp.27501","volume":"234","author":"Y Li","year":"2019","unstructured":"Li Y, et al. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome. J Cell Physiol. 2019;234(5):7435\u201347.","journal-title":"J Cell Physiol"},{"issue":"11","key":"1690_CR50","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s40618-016-0472-2","volume":"39","author":"M Karakose","year":"2016","unstructured":"Karakose M, et al. Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome. J Endocrinol Invest. 2016;39(11):1269\u201375.","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"1690_CR51","doi-asserted-by":"publisher","first-page":"10689","DOI":"10.1007\/s11033-022-07695-5","volume":"49","author":"M Shamsi","year":"2022","unstructured":"Shamsi M, et al. The immune system\u2019s role in PCOS. Mol Biol Rep. 2022;49(11):10689\u2013702.","journal-title":"Mol Biol Rep"},{"key":"1690_CR52","doi-asserted-by":"publisher","first-page":"103628","DOI":"10.1016\/j.jri.2022.103628","volume":"151","author":"Y Zhai","year":"2022","unstructured":"Zhai Y, Pang Y. Systemic and ovarian inflammation in women with polycystic ovary syndrome. J Reprod Immunol. 2022;151:103628.","journal-title":"J Reprod Immunol"},{"key":"1690_CR53","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3389\/fendo.2019.00879","volume":"10","author":"F Cirillo","year":"2019","unstructured":"Cirillo F, et al. MiRNAs regulating insulin sensitivity are dysregulated in polycystic ovary syndrome (PCOS) ovaries and are associated with markers of inflammation and insulin sensitivity. Front Endocrinol (Lausanne). 2019;10:879.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1690_CR54","doi-asserted-by":"publisher","first-page":"670711","DOI":"10.3389\/fcell.2021.670711","volume":"9","author":"J Luo","year":"2021","unstructured":"Luo J, Xu T, Sun K. N6-Methyladenosine RNA modification in inflammation: roles, mechanisms, and applications. Front Cell Dev Biol. 2021;9:670711.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"1690_CR55","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/WNR.0000000000001550","volume":"33","author":"L Wen","year":"2022","unstructured":"Wen L, et al. The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6\/NF-\u03baB pathway. NeuroReport. 2022;33(6):243\u201351.","journal-title":"NeuroReport"},{"issue":"Pt 1","key":"1690_CR56","doi-asserted-by":"publisher","first-page":"113327","DOI":"10.1016\/j.intimp.2024.113327","volume":"143","author":"L Weng","year":"2024","unstructured":"Weng L, et al. METTL3-mediated m(6)A modification of CD36: Implications for glucose metabolism and inflammatory dysregulation in follicles of polycystic ovary syndrome. Int Immunopharmacol. 2024;143(Pt 1):113327.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"1690_CR57","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10735-024-10257-7","volume":"55","author":"C Shen","year":"2024","unstructured":"Shen C, et al. METTL3 silencing inhibits ferroptosis to suppress ovarian fibrosis in PCOS by upregulating m6A modification of GPX4. J Mol Histol. 2024;55(6):1163\u201375.","journal-title":"J Mol Histol"},{"issue":"1","key":"1690_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-022-00350-8","volume":"27","author":"J Lan","year":"2022","unstructured":"Lan J, et al. WTAP-mediated N(6)-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy. Cell Mol Biol Lett. 2022;27(1):51.","journal-title":"Cell Mol Biol Lett"},{"issue":"50","key":"1690_CR59","doi-asserted-by":"publisher","first-page":"41732","DOI":"10.1074\/jbc.M112.381228","volume":"287","author":"PR Vajjhala","year":"2012","unstructured":"Vajjhala PR, Mirams RE, Hill JM. Multiple binding sites on the pyrin domain of ASC protein allow self-association and interaction with NLRP3 protein. J Biol Chem. 2012;287(50):41732\u201343.","journal-title":"J Biol Chem"},{"issue":"7","key":"1690_CR60","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00018-016-2396-6","volume":"74","author":"F Hoss","year":"2017","unstructured":"Hoss F, Rodriguez-Alcazar JF, Latz E. Assembly and regulation of ASC specks. Cell Mol Life Sci. 2017;74(7):1211\u201329.","journal-title":"Cell Mol Life Sci"},{"key":"1690_CR61","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301\u201316.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"1690_CR62","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17(8):588\u2013606.","journal-title":"Nat Rev Drug Discov"},{"key":"1690_CR63","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"BZ Shao","year":"2015","unstructured":"Shao BZ, et al. NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol. 2015;6:262.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1690_CR64","doi-asserted-by":"publisher","first-page":"103129","DOI":"10.1016\/j.arcmed.2024.103129","volume":"56","author":"R Heidarzadehpilehrood","year":"2024","unstructured":"Heidarzadehpilehrood R, et al. A high-throughput RNA sequency of peripheral blood mononuclear cells reveals on inflammatory state in women with PCOS. Arch Med Res. 2024;56(3):103129.","journal-title":"Arch Med Res"},{"issue":"2","key":"1690_CR65","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ncrna.2024.01.002","volume":"9","author":"R Heidarzadehpilehrood","year":"2024","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M. Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS). Noncoding RNA Res. 2024;9(2):624\u201340.","journal-title":"Noncoding RNA Res"},{"issue":"6","key":"1690_CR66","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1055\/s-0032-1328878","volume":"30","author":"RS Legro","year":"2012","unstructured":"Legro RS. Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med. 2012;30(6):496\u2013506.","journal-title":"Semin Reprod Med"},{"issue":"1","key":"1690_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1210\/jc.2005-1804","volume":"91","author":"JP Baillargeon","year":"2006","unstructured":"Baillargeon JP, Nestler JE. Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab. 2006;91(1):22\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"36","key":"1690_CR68","doi-asserted-by":"publisher","first-page":"e4526","DOI":"10.1097\/MD.0000000000004526","volume":"95","author":"XL Zeng","year":"2016","unstructured":"Zeng XL, et al. Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Medicine (Baltimore). 2016;95(36):e4526.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1690_CR69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1185\/03007995.2012.755121","volume":"29","author":"CJ Glueck","year":"2013","unstructured":"Glueck CJ, et al. Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome. Curr Med Res Opin. 2013;29(1):55\u201362.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"1690_CR70","first-page":"165","volume":"84","author":"RS Legro","year":"1999","unstructured":"Legro RS, et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84(1):165\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1690_CR71","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1530\/REP-18-0583","volume":"158","author":"AP Snider","year":"2019","unstructured":"Snider AP, Wood JR. Obesity induces ovarian inflammation and reduces oocyte quality. Reproduction. 2019;158(3):R79-r90.","journal-title":"Reproduction"},{"issue":"6","key":"1690_CR72","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas M, Dunaif A. Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr Rev. 2022;43(6):927\u201365.","journal-title":"Endocr Rev"},{"issue":"6","key":"1690_CR73","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.molcel.2018.08.011","volume":"71","author":"J Wei","year":"2018","unstructured":"Wei J, et al. Differential m(6)A, m(6)A(m), and m(1)A demethylation mediated by FTO in the cell nucleus and cytoplasm. Mol Cell. 2018;71(6):973-985.e5.","journal-title":"Mol Cell"},{"issue":"10","key":"1690_CR74","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1007\/s00125-012-2638-6","volume":"55","author":"P Wojciechowski","year":"2012","unstructured":"Wojciechowski P, et al. Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis. Diabetologia. 2012;55(10):2636\u201345.","journal-title":"Diabetologia"},{"issue":"10","key":"1690_CR75","first-page":"13505","volume":"8","author":"H Xue","year":"2015","unstructured":"Xue H, et al. Association of common variants of FTO in women with polycystic ovary syndrome. Int J Clin Exp Pathol. 2015;8(10):13505\u20139.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"1690_CR76","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s43032-021-00664-6","volume":"29","author":"L Zhou","year":"2022","unstructured":"Zhou L, et al. N6-methyladenosine demethylase FTO induces the dysfunctions of ovarian granulosa cells by upregulating flotillin 2. Reprod Sci. 2022;29(4):1305\u201315.","journal-title":"Reprod Sci"},{"issue":"1","key":"1690_CR77","doi-asserted-by":"publisher","first-page":"E148","DOI":"10.1210\/jc.2014-1893","volume":"100","author":"F Shen","year":"2015","unstructured":"Shen F, et al. Decreased N(6)-methyladenosine in peripheral blood RNA from diabetic patients is associated with FTO expression rather than ALKBH5. J Clin Endocrinol Metab. 2015;100(1):E148\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1690_CR78","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1210\/jc.2018-00619","volume":"104","author":"Y Yang","year":"2019","unstructured":"Yang Y, et al. Glucose is involved in the dynamic regulation of m6A in patients with type 2 diabetes. J Clin Endocrinol Metab. 2019;104(3):665\u201373.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1690_CR79","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMoa1502214","volume":"373","author":"M Claussnitzer","year":"2015","unstructured":"Claussnitzer M, et al. FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med. 2015;373(10):895\u2013907.","journal-title":"N Engl J Med"},{"issue":"7492","key":"1690_CR80","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature13138","volume":"507","author":"S Smemo","year":"2014","unstructured":"Smemo S, et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature. 2014;507(7492):371\u20135.","journal-title":"Nature"},{"issue":"4","key":"1690_CR81","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4093\/dmj.2014.38.4.302","volume":"38","author":"DK Song","year":"2014","unstructured":"Song DK, et al. FTO gene variants are associated with PCOS susceptibility and hyperandrogenemia in young Korean women. Diabetes Metab J. 2014;38(4):302\u201310.","journal-title":"Diabetes Metab J"},{"issue":"4","key":"1690_CR82","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.metabol.2009.08.023","volume":"59","author":"E Wehr","year":"2010","unstructured":"Wehr E, et al. Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome. Metabolism. 2010;59(4):575\u201380.","journal-title":"Metabolism"},{"issue":"4","key":"1690_CR83","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.diabet.2009.03.004","volume":"35","author":"I Kowalska","year":"2009","unstructured":"Kowalska I, et al. The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes. Diabetes Metab. 2009;35(4):328\u201331.","journal-title":"Diabetes Metab"},{"issue":"2","key":"1690_CR84","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","volume":"26","author":"KS Ruth","year":"2020","unstructured":"Ruth KS, et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020;26(2):252\u20138.","journal-title":"Nat Med"},{"issue":"Pt A","key":"1690_CR85","doi-asserted-by":"publisher","first-page":"111141","DOI":"10.1016\/j.intimp.2023.111141","volume":"125","author":"Y Xiang","year":"2023","unstructured":"Xiang Y, et al. Hyperandrogenism drives ovarian inflammation and pyroptosis: a possible pathogenesis of PCOS follicular dysplasia. Int Immunopharmacol. 2023;125(Pt A):111141.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"1690_CR86","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/humupd\/dmx013","volume":"23","author":"P Filippou","year":"2017","unstructured":"Filippou P, Homburg R. Is foetal hyperexposure to androgens a cause of PCOS? Hum Reprod Update. 2017;23(4):421\u201332.","journal-title":"Hum Reprod Update"},{"issue":"25","key":"1690_CR87","doi-asserted-by":"publisher","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","volume":"95","author":"RS Legro","year":"1998","unstructured":"Legro RS, et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A. 1998;95(25):14956\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1690_CR88","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1177\/1933719116678689","volume":"24","author":"F Plaza-Parrochia","year":"2017","unstructured":"Plaza-Parrochia F, et al. Molecular mechanisms of androstenediol in the regulation of the proliferative process of human endometrial cells. Reprod Sci. 2017;24(7):1079\u201387.","journal-title":"Reprod Sci"},{"issue":"5","key":"1690_CR89","first-page":"1967","volume":"7","author":"HM Mokhtar","year":"2014","unstructured":"Mokhtar HM, et al. Testosterone decreases the expression of endometrial pinopode and L-selectin ligand (MECA-79) in adult female rats during uterine receptivity period. Int J Clin Exp Pathol. 2014;7(5):1967\u201376.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"1690_CR90","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1210\/jc.2011-2366","volume":"97","author":"D Gonzalez","year":"2012","unstructured":"Gonzalez D, et al. Loss of WT1 expression in the endometrium of infertile PCOS patients: a hyperandrogenic effect? J Clin Endocrinol Metab. 2012;97(3):957\u201366.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1a","key":"1690_CR91","first-page":"1","volume":"21","author":"A Zaia","year":"2001","unstructured":"Zaia A, et al. Transcriptional regulation of the androgen signaling pathway by the Wilms\u2019 tumor suppressor gene WT1. Anticancer Res. 2001;21(1a):1\u201310.","journal-title":"Anticancer Res"},{"issue":"12","key":"1690_CR92","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1055\/s-0035-1555806","volume":"47","author":"V Garc\u00eda","year":"2015","unstructured":"Garc\u00eda V, et al. Endometria from obese PCOS women with hyperinsulinemia exhibit altered adiponectin signaling. Horm Metab Res. 2015;47(12):901\u20139.","journal-title":"Horm Metab Res"},{"issue":"5","key":"1690_CR93","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1111\/jcmm.14923","volume":"24","author":"D Ujvari","year":"2020","unstructured":"Ujvari D, Graells Brugalla C, Hirschberg AL. Dihydrotestosterone potentiates insulin to up-regulate prokineticin-1 in decidualizing human endometrial stromal cells. J Cell Mol Med. 2020;24(5):3242\u20135.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"1690_CR94","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/j.fertnstert.2009.01.096","volume":"93","author":"L Zhang","year":"2010","unstructured":"Zhang L, Liao Q. Effects of testosterone and metformin on glucose metabolism in endometrium. Fertil Steril. 2010;93(7):2295\u20138.","journal-title":"Fertil Steril"},{"issue":"8","key":"1690_CR95","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s43032-020-00194-7","volume":"27","author":"MH Lee","year":"2020","unstructured":"Lee MH, et al. Hyperandrogenic milieu dysregulates the expression of insulin signaling factors and glucose transporters in the endometrium of patients with polycystic ovary syndrome. Reprod Sci. 2020;27(8):1637\u201347.","journal-title":"Reprod Sci"},{"issue":"1","key":"1690_CR96","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12881-020-0961-1","volume":"21","author":"U Branavan","year":"2020","unstructured":"Branavan U, et al. In depth analysis of the association of FTO SNP (rs9939609) with the expression of classical phenotype of PCOS: a Sri Lankan study. BMC Med Genet. 2020;21(1):30.","journal-title":"BMC Med Genet"},{"issue":"1","key":"1690_CR97","doi-asserted-by":"publisher","first-page":"2276167","DOI":"10.1080\/09513590.2023.2276167","volume":"39","author":"YX Jing","year":"2023","unstructured":"Jing YX, et al. N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway. Gynecol Endocrinol. 2023;39(1):2276167.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"1690_CR98","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7150\/ijbs.31425","volume":"15","author":"T Wang","year":"2019","unstructured":"Wang T, et al. Differential expression patterns of glycolytic enzymes and mitochondria-dependent apoptosis in PCOS patients with endometrial hyperplasia, an early hallmark of endometrial cancer, in vivo and the impact of metformin in vitro. Int J Biol Sci. 2019;15(3):714\u201325.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"1690_CR99","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","volume":"27","author":"S Palomba","year":"2021","unstructured":"Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2021;27(3):584\u2013618.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"1690_CR100","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/eje.0.1500161","volume":"150","author":"A Lukanova","year":"2004","unstructured":"Lukanova A, et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol. 2004;150(2):161\u201371.","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"1690_CR101","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.fertnstert.2006.12.055","volume":"88","author":"JP Baillargeon","year":"2007","unstructured":"Baillargeon JP, Carpentier A. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertil Steril. 2007;88(4):886\u201393.","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"1690_CR102","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/S0140-6736(15)60331-2","volume":"385","author":"M O'Reilly","year":"2015","unstructured":"O\u2019Reilly M, et al. Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome. Lancet. 2015;385(Suppl 1):S16.","journal-title":"Lancet"},{"issue":"5","key":"1690_CR103","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/09513590312331290268","volume":"17","author":"S Coffey","year":"2003","unstructured":"Coffey S, Mason H. The effect of polycystic ovary syndrome on health-related quality of life. Gynecol Endocrinol. 2003;17(5):379\u201386.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"1690_CR104","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","volume":"109","author":"A Dokras","year":"2018","unstructured":"Dokras A, et al. Androgen excess- polycystic ovary syndrome society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018;109(5):888\u201399.","journal-title":"Fertil Steril"},{"issue":"2","key":"1690_CR105","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.fertnstert.2019.03.027","volume":"112","author":"CT Tay","year":"2019","unstructured":"Tay CT, et al. Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: a community-based cohort study. Fertil Steril. 2019;112(2):353\u201361.","journal-title":"Fertil Steril"},{"issue":"6","key":"1690_CR106","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.4106","volume":"22","author":"V Rothhammer","year":"2016","unstructured":"Rothhammer V, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med. 2016;22(6):586\u201397.","journal-title":"Nat Med"},{"issue":"2","key":"1690_CR107","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39(2):372\u201385.","journal-title":"Immunity"},{"issue":"3","key":"1690_CR108","doi-asserted-by":"publisher","first-page":"721","DOI":"10.7150\/thno.31562","volume":"9","author":"L Sun","year":"2019","unstructured":"Sun L, et al. Fto deficiency reduces anxiety- and depression-like behaviors in mice via alterations in gut microbiota. Theranostics. 2019;9(3):721\u201333.","journal-title":"Theranostics"},{"issue":"1","key":"1690_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1894070","volume":"13","author":"X Qi","year":"2021","unstructured":"Qi X, et al. The impact of the gut microbiota on the reproductive and metabolic endocrine system. Gut Microbes. 2021;13(1):1\u201321.","journal-title":"Gut Microbes"},{"key":"1690_CR110","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fendo.2014.00047","volume":"5","author":"PJ Parekh","year":"2014","unstructured":"Parekh PJ, et al. The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome. Front Endocrinol (Lausanne). 2014;5:47.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7610","key":"1690_CR111","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature18846","volume":"535","author":"JL Sonnenburg","year":"2016","unstructured":"Sonnenburg JL, B\u00e4ckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535(7610):56\u201364.","journal-title":"Nature"},{"key":"1690_CR112","first-page":"15","volume":"1","author":"R Nagpal","year":"2014","unstructured":"Nagpal R, Yadav H, Marotta F. Gut microbiota: the next-gen frontier in preventive and therapeutic medicine? Front Med (Lausanne). 2014;1:15.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1690_CR113","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","volume":"79","author":"K Tremellen","year":"2012","unstructured":"Tremellen K, Pearce K. Dysbiosis of Gut Microbiota (DOGMA)\u2013a novel theory for the development of Polycystic Ovarian Syndrome. Med Hypotheses. 2012;79(1):104\u201312.","journal-title":"Med Hypotheses"},{"key":"1690_CR114","doi-asserted-by":"publisher","first-page":"933110","DOI":"10.3389\/fendo.2022.933110","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, et al. Present and future: crosstalks between polycystic ovary syndrome and gut metabolites relating to gut microbiota. Front Endocrinol (Lausanne). 2022;13:933110.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1690_CR115","doi-asserted-by":"publisher","first-page":"808508","DOI":"10.3389\/fendo.2022.808508","volume":"13","author":"Y Gu","year":"2022","unstructured":"Gu Y, et al. Gut and vaginal microbiomes in PCOS: implications for women\u2019s health. Front Endocrinol (Lausanne). 2022;13:808508.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"28","key":"1690_CR116","doi-asserted-by":"publisher","first-page":"e2307981","DOI":"10.1002\/advs.202307981","volume":"11","author":"M Yang","year":"2024","unstructured":"Yang M, et al. Antibiotic-induced gut microbiota dysbiosis modulates host transcriptome and m(6)A epitranscriptome via bile acid metabolism. Adv Sci (Weinh). 2024;11(28):e2307981.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"1690_CR117","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.resmic.2018.09.002","volume":"170","author":"B Zeng","year":"2019","unstructured":"Zeng B, et al. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study. Res Microbiol. 2019;170(1):43\u201352.","journal-title":"Res Microbiol"},{"issue":"8","key":"1690_CR118","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","volume":"25","author":"X Qi","year":"2019","unstructured":"Qi X, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25(8):1225\u201333.","journal-title":"Nat Med"},{"key":"1690_CR119","doi-asserted-by":"publisher","first-page":"103852","DOI":"10.1016\/j.critrevonc.2022.103852","volume":"180","author":"HP Throwba","year":"2022","unstructured":"Throwba HP, et al. The epigenetic correlation among ovarian cancer, endometriosis and PCOS: a review. Crit Rev Oncol Hematol. 2022;180:103852.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"1690_CR120","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metab. 2021;106(3):e1071\u201383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1690_CR121","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40618-021-01666-6","volume":"45","author":"JJ Ge","year":"2022","unstructured":"Ge JJ, et al. The effectiveness and safety of liraglutide in treating overweight\/obese patients with polycystic ovary syndrome: a meta-analysis. J Endocrinol Invest. 2022;45(2):261\u201373.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1690_CR122","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/ejendo\/lvad098","volume":"189","author":"J Melin","year":"2023","unstructured":"Melin J, et al. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Eur J Endocrinol. 2023;189(2):S37-s63.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1690_CR123","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmv025","volume":"21","author":"N Naderpoor","year":"2015","unstructured":"Naderpoor N, et al. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update. 2015;21(5):560\u201374.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"1690_CR124","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364\u201379.","journal-title":"Fertil Steril"},{"issue":"2","key":"1690_CR125","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u201388.","journal-title":"Fertil Steril"},{"issue":"11","key":"1690_CR126","first-page":"973","volume":"20","author":"P Lohrasbi","year":"2022","unstructured":"Lohrasbi P, et al. The effects of melatonin and metformin on histological characteristics of the ovary and uterus in letrozole-induced polycystic ovarian syndrome mice: A stereological study. Int J Reprod Biomed. 2022;20(11):973\u201388.","journal-title":"Int J Reprod Biomed"},{"issue":"1","key":"1690_CR127","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12967-020-02277-0","volume":"18","author":"A Paoli","year":"2020","unstructured":"Paoli A, et al. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med. 2020;18(1):104.","journal-title":"J Transl Med"},{"issue":"1","key":"1690_CR128","doi-asserted-by":"publisher","first-page":"2085961","DOI":"10.1080\/19490976.2022.2085961","volume":"14","author":"V Rodriguez Paris","year":"2022","unstructured":"Rodriguez Paris V, et al. The interplay between PCOS pathology and diet on gut microbiota in a mouse model. Gut Microbes. 2022;14(1):2085961.","journal-title":"Gut Microbes"},{"issue":"7","key":"1690_CR129","doi-asserted-by":"publisher","first-page":"e14117","DOI":"10.1111\/jfbc.14117","volume":"46","author":"R Shahid","year":"2022","unstructured":"Shahid R, et al. Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS). J Food Biochem. 2022;46(7):e14117.","journal-title":"J Food Biochem"},{"issue":"1","key":"1690_CR130","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12944-017-0539-x","volume":"16","author":"MM Rahman","year":"2017","unstructured":"Rahman MM, et al. Cardamom powder supplementation prevents obesity, improves glucose intolerance, inflammation and oxidative stress in liver of high carbohydrate high fat diet induced obese rats. Lipids Health Dis. 2017;16(1):151.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"1690_CR131","first-page":"189","volume":"2","author":"QQ Dinh","year":"2007","unstructured":"Dinh QQ, Sinclair R. Female pattern hair loss: current treatment concepts. Clin Interv Aging. 2007;2(2):189\u201399.","journal-title":"Clin Interv Aging"},{"key":"1690_CR132","doi-asserted-by":"publisher","first-page":"64","DOI":"10.21037\/sci.2017.06.07","volume":"4","author":"S Garg","year":"2017","unstructured":"Garg S, Manchanda S. Platelet-rich plasma-an \u201cElixir\u201d for treatment of alopecia: personal experience on 117 patients with review of literature. Stem Cell Investig. 2017;4:64.","journal-title":"Stem Cell Investig"},{"issue":"5","key":"1690_CR133","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/DSS.0000000000001049","volume":"43","author":"E Anitua","year":"2017","unstructured":"Anitua E, et al. The effect of plasma rich in growth factors on pattern hair loss: a pilot Study. Dermatol Surg. 2017;43(5):658\u201370.","journal-title":"Dermatol Surg"},{"key":"1690_CR134","doi-asserted-by":"publisher","first-page":"58","DOI":"10.21037\/sci.2017.06.04","volume":"4","author":"P Gentile","year":"2017","unstructured":"Gentile P, et al. Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss. Stem Cell Investig. 2017;4:58.","journal-title":"Stem Cell Investig"},{"issue":"7","key":"1690_CR135","first-page":"18","volume":"13","author":"S Fonseka","year":"2020","unstructured":"Fonseka S, et al. Effectiveness of low-dose ethinylestradiol\/cyproterone acetate and ethinylestradiol\/desogestrel with and without metformin on hirsutism in polycystic ovary syndrome: a randomized, double-blind. Triple-dummy Study J Clin Aesthet Dermatol. 2020;13(7):18\u201323.","journal-title":"Triple-dummy Study J Clin Aesthet Dermatol"},{"issue":"6","key":"1690_CR136","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/jdv.13579","volume":"30","author":"E Araviiskaia","year":"2016","unstructured":"Araviiskaia E, Dr\u00e9no B. The role of topical dermocosmetics in acne vulgaris. J Eur Acad Dermatol Venereol. 2016;30(6):926\u201335.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"1690_CR137","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.sder.2008.06.003","volume":"27","author":"SJ Kempiak","year":"2008","unstructured":"Kempiak SJ, Uebelhoer N. Superficial chemical peels and microdermabrasion for acne vulgaris. Semin Cutan Med Surg. 2008;27(3):212\u201320.","journal-title":"Semin Cutan Med Surg"},{"issue":"3","key":"1690_CR138","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/jocd.12367","volume":"16","author":"MH Gold","year":"2017","unstructured":"Gold MH, Goldberg DJ, Nestor MS. Current treatments of acne: Medications, lights, lasers, and a novel 650-\u03bcs 1064-nm Nd: YAG laser. J Cosmet Dermatol. 2017;16(3):303\u201318.","journal-title":"J Cosmet Dermatol"},{"issue":"10","key":"1690_CR139","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1210\/jc.2005-2250","volume":"91","author":"A Gambineri","year":"2006","unstructured":"Gambineri A, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. J Clin Endocrinol Metab. 2006;91(10):3970\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1690_CR140","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1210\/jc.2016-1896","volume":"101","author":"A Dokras","year":"2016","unstructured":"Dokras A, et al. Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS. J Clin Endocrinol Metab. 2016;101(8):2966\u201374.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1690_CR141","doi-asserted-by":"publisher","first-page":"e0233876","DOI":"10.1371\/journal.pone.0233876","volume":"15","author":"G Jiskoot","year":"2020","unstructured":"Jiskoot G, et al. Long-term effects of a three-component lifestyle intervention on emotional well-being in women with polycystic ovary syndrome (PCOS): a secondary analysis of a randomized controlled trial. PLoS ONE. 2020;15(6):e0233876.","journal-title":"PLoS ONE"},{"issue":"1","key":"1690_CR142","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.fertnstert.2018.03.028","volume":"110","author":"LG Cooney","year":"2018","unstructured":"Cooney LG, et al. Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial. Fertil Steril. 2018;110(1):161-171.e1.","journal-title":"Fertil Steril"},{"key":"1690_CR143","doi-asserted-by":"publisher","first-page":"854796","DOI":"10.3389\/fcimb.2022.854796","volume":"12","author":"H Zhao","year":"2022","unstructured":"Zhao H, et al. Modified banxia xiexin decoction ameliorates polycystic ovarian syndrome with insulin resistance by regulating intestinal microbiota. Front Cell Infect Microbiol. 2022;12:854796.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"1690_CR144","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1159\/000518040","volume":"86","author":"HR Shen","year":"2021","unstructured":"Shen HR, et al. Berberine improves the symptoms of DHEA-induced PCOS rats by regulating gut microbiotas and metabolites. Gynecol Obstet Invest. 2021;86(4):388\u201397.","journal-title":"Gynecol Obstet Invest"},{"key":"1690_CR145","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3389\/fendo.2020.00575","volume":"11","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, et al. Guizhi Fuling Wan, Chinese herbal medicine, ameliorates insulin sensitivity in PCOS model rats with insulin resistance via remodeling intestinal homeostasis. Front Endocrinol (Lausanne). 2020;11:575.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1690_CR146","doi-asserted-by":"publisher","first-page":"113821","DOI":"10.1016\/j.jep.2021.113821","volume":"270","author":"M Liu","year":"2021","unstructured":"Liu M, et al. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K\/AKT\/mTOR signaling pathway. J Ethnopharmacol. 2021;270:113821.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"1690_CR147","doi-asserted-by":"publisher","first-page":"e13644","DOI":"10.1111\/aji.13644","volume":"89","author":"S Vaez","year":"2023","unstructured":"Vaez S, et al. Quercetin and polycystic ovary syndrome; inflammation, hormonal parameters and pregnancy outcome: a randomized clinical trial. Am J Reprod Immunol. 2023;89(3):e13644.","journal-title":"Am J Reprod Immunol"},{"key":"1690_CR148","doi-asserted-by":"publisher","first-page":"101886","DOI":"10.1016\/j.redox.2021.101886","volume":"41","author":"T Li","year":"2021","unstructured":"Li T, et al. Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction. Redox Biol. 2021;41:101886.","journal-title":"Redox Biol"},{"issue":"7","key":"1690_CR149","doi-asserted-by":"publisher","first-page":"300060521103175","DOI":"10.1177\/03000605211031758","volume":"49","author":"C Miao","year":"2021","unstructured":"Miao C, et al. Effects of probiotic and synbiotic supplementation on insulin resistance in women with polycystic ovary syndrome: a meta-analysis. J Int Med Res. 2021;49(7):3000605211031758.","journal-title":"J Int Med Res"},{"key":"1690_CR150","doi-asserted-by":"publisher","first-page":"1142041","DOI":"10.3389\/fcimb.2023.1142041","volume":"13","author":"Y Sun","year":"2023","unstructured":"Sun Y, et al. Gut microbiota dysbiosis in polycystic ovary syndrome: mechanisms of progression and clinical applications. Front Cell Infect Microbiol. 2023;13:1142041.","journal-title":"Front Cell Infect Microbiol"},{"issue":"20","key":"1690_CR151","doi-asserted-by":"publisher","first-page":"11874","DOI":"10.1111\/jcmm.15807","volume":"24","author":"S Zhang","year":"2020","unstructured":"Zhang S, et al. Altered m(6) A modification is involved in up-regulated expression of FOXO3 in luteinized granulosa cells of non-obese polycystic ovary syndrome patients. J Cell Mol Med. 2020;24(20):11874\u201382.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1690_CR152","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/advances\/nmx009","volume":"9","author":"H Liu","year":"2018","unstructured":"Liu H, et al. Butyrate: a double-edged sword for health? Adv Nutr. 2018;9(1):21\u20139.","journal-title":"Adv Nutr"},{"issue":"2","key":"1690_CR153","doi-asserted-by":"publisher","first-page":"e00017","DOI":"10.1128\/mSystems.00017-19","volume":"4","author":"J Zhang","year":"2019","unstructured":"Zhang J, et al. Probiotic bifidobacterium lactis V9 Regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis. mSystems. 2019;4(2):e00017-19.","journal-title":"mSystems"},{"issue":"7","key":"1690_CR154","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s10096-015-2355-4","volume":"34","author":"S Murugesan","year":"2015","unstructured":"Murugesan S, et al. Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children. Eur J Clin Microbiol Infect Dis. 2015;34(7):1337\u201346.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"1690_CR155","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41422-018-0127-2","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang X, et al. Transcriptome-wide reprogramming of N(6)-methyladenosine modification by the mouse microbiome. Cell Res. 2019;29(2):167\u201370.","journal-title":"Cell Res"},{"issue":"1","key":"1690_CR156","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrendo.2013.227","volume":"10","author":"RJ Loos","year":"2014","unstructured":"Loos RJ, Yeo GS. The bigger picture of FTO: the first GWAS-identified obesity gene. Nat Rev Endocrinol. 2014;10(1):51\u201361.","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"1690_CR157","doi-asserted-by":"publisher","first-page":"e71901","DOI":"10.1371\/journal.pone.0071901","volume":"8","author":"C Liu","year":"2013","unstructured":"Liu C, Mou S, Pan C. The FTO gene rs9939609 polymorphism predicts risk of cardiovascular disease: a systematic review and meta-analysis. PLoS ONE. 2013;8(8):e71901.","journal-title":"PLoS ONE"},{"issue":"5","key":"1690_CR158","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00404-020-05895-7","volume":"303","author":"X Sun","year":"2021","unstructured":"Sun X, et al. Decreased expression of m(6)A demethylase FTO in ovarian aging. Arch Gynecol Obstet. 2021;303(5):1363\u20139.","journal-title":"Arch Gynecol Obstet"},{"issue":"8","key":"1690_CR159","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41419-021-04016-9","volume":"12","author":"ZX Jiang","year":"2021","unstructured":"Jiang ZX, et al. The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging. Cell Death Dis. 2021;12(8):744.","journal-title":"Cell Death Dis"},{"key":"1690_CR160","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2350-11-12","volume":"11","author":"S Tan","year":"2010","unstructured":"Tan S, et al. Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). BMC Med Genet. 2010;11:12.","journal-title":"BMC Med Genet"},{"issue":"3\u20134","key":"1690_CR161","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1900\/RDS.2014.11.258","volume":"11","author":"P Azimi","year":"2014","unstructured":"Azimi P, et al. Effects of cinnamon, cardamom, saffron, and ginger consumption on markers of glycemic control, lipid profile, oxidative stress, and inflammation in Type 2 diabetes patients. Rev Diabet Stud. 2014;11(3\u20134):258\u201366.","journal-title":"Rev Diabet Stud"},{"issue":"2","key":"1690_CR162","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbagrm.2018.12.009","volume":"1862","author":"L Moody","year":"2019","unstructured":"Moody L, et al. Epigenetic regulation of carnitine palmitoyltransferase 1 (Cpt1a) by high fat diet. Biochim Biophys Acta Gene Regul Mech. 2019;1862(2):141\u201352.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"5","key":"1690_CR163","doi-asserted-by":"publisher","first-page":"R816","DOI":"10.1152\/ajpregu.00520.2016","volume":"312","author":"JD Warfel","year":"2017","unstructured":"Warfel JD, et al. Examination of carnitine palmitoyltransferase 1 abundance in white adipose tissue: implications in obesity research. Am J Physiol Regul Integr Comp Physiol. 2017;312(5):R816-r820.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"1690_CR164","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12905-018-0706-x","volume":"19","author":"MH Daghestani","year":"2019","unstructured":"Daghestani MH, et al. The influence of the rs1137101 genotypes of leptin receptor gene on the demographic and metabolic profile of normal Saudi females and those suffering from polycystic ovarian syndrome. BMC Womens Health. 2019;19(1):10.","journal-title":"BMC Womens Health"},{"issue":"1","key":"1690_CR165","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.gene.2013.05.074","volume":"527","author":"L Li","year":"2013","unstructured":"Li L, et al. Relationship between leptin receptor and polycystic ovary syndrome. Gene. 2013;527(1):71\u20134.","journal-title":"Gene"},{"issue":"12","key":"1690_CR166","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/1535-7163.MCT-06-0478","volume":"5","author":"PL Kuo","year":"2006","unstructured":"Kuo PL, Hsu YL, Cho CY. Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT\/mammalian target of rapamycin pathway in breast cancer cells. Mol Cancer Ther. 2006;5(12):3209\u201321.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"1690_CR167","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1389557520666201116144421","volume":"21","author":"A Roy","year":"2021","unstructured":"Roy A. Plumbagin: a potential anti-cancer Compound. Mini Rev Med Chem. 2021;21(6):731\u20137.","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"1690_CR168","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/19768354.2020.1790416","volume":"24","author":"Z Cai","year":"2020","unstructured":"Cai Z, et al. Plumbagin inhibits proliferation and promotes apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inactivating PI3K\/Akt\/mTOR pathway. Anim Cells Syst (Seoul). 2020;24(4):197\u2013204.","journal-title":"Anim Cells Syst (Seoul)"},{"issue":"09","key":"1690_CR169","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.29271\/jcpsp.2022.09.1143","volume":"32","author":"E Onalan","year":"2022","unstructured":"Onalan E, et al. m6A RNA, FTO, ALKBH5 Expression in Type 2 Diabetic and Obesity Patients. J Coll Physicians Surg Pak. 2022;32(09):1143\u20138.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"1690_CR170","doi-asserted-by":"publisher","first-page":"2181637","DOI":"10.1080\/09513590.2023.2181637","volume":"39","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhou H, Ding C. The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt\/\u03b2-catenin pathway. Gynecol Endocrinol. 2023;39(1):2181637.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"1690_CR171","doi-asserted-by":"publisher","first-page":"651","DOI":"10.15171\/apb.2017.078","volume":"7","author":"M Sadeghi Ataabadi","year":"2017","unstructured":"Sadeghi Ataabadi M, et al. Role of essential oil of mentha spicata (Spearmint) in addressing reverse hormonal and folliculogenesis disturbances in a polycystic ovarian syndrome in a rat model. Adv Pharm Bull. 2017;7(4):651\u20134.","journal-title":"Adv Pharm Bull"},{"key":"1690_CR172","doi-asserted-by":"publisher","first-page":"1294406","DOI":"10.3389\/fendo.2023.1294406","volume":"14","author":"S Malik","year":"2023","unstructured":"Malik S, et al. Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs. Front Endocrinol (Lausanne). 2023;14:1294406.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01690-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01690-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01690-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:05:33Z","timestamp":1748001933000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01690-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":172,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1690"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01690-7","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conmpeting interests"}}],"article-number":"107"}}